Auto Added by WPeMatico
Agency officials promise fast reviews of new treatments while vowing they will not be a “rubber stamp” for the industry. But patients with rare diseases view recent decisions as signs that the doors are closing on their options.
F.D.A. Faces Upset Over Denials of New Drugs Read More »
The Trump administration is proposing Obamacare plans that it says will lower health insurance premiums. But critics warn they would make care unaffordable.
New A.C.A. Plans Could Increase Family Deductibles to $31,000 Read More »
Federal policies under Robert F. Kennedy Jr. that are hostile to vaccines have “sent a chill through the entire industry,” one scientist said.
Vaccine Makers Curtail Research and Cut Jobs Read More »
One panelist accused the F.D.A. of withholding data on potential harms. The advisers also are reviewing research on vaccines given to pregnant women.
Federal Vaccine Advisers Take Aim at Covid Shots Read More »
Psilocybin-assisted therapy is legal in three states, but access has so far been limited and expensive.
’Shrooms Lead the Pack in Psychedelic Medicine, but Rollout Is Bumpy Read More »
Proposed new rules would punish the hospitals by pulling all federal financing. Advocates say lawsuits will follow.
Trump Moves to End Gender-Related Care for Minors, Threatening Hospitals That Offer It Read More »
The agency claimed that 10 children’s deaths were linked to the shots, although it did not release evidence to support the assertions.
FDA Expands Covid Vaccine Inquiry to Adult Deaths Read More »
